1-[3-(Trifluoromethyl)phenyl]cyclobutan-1-amine | 1094218-35-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-[3-(Trifluoromethyl)phenyl]cyclobutan-1-amine
• CAS: 1094218-35-5
• 化学式: C₁₁H₁₂F₃N
• mdl: MFCD09910048
• 分子量: 215.218
• InChiKey: YRMXYMIMWFKYSY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-[3-(Trifluoromethyl)phenyl]cyclobutan-1-amine 、 在 benzotriazol-1-yloxy-tris(dimethylamino)-phosphonium chloride 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 以35%的产率得到(1R,2R)-2-(5-phenylisoxazol-3-yl)-N-(1-(3-(trifluoromethyl)phenyl)cyclobutyl)cyclopentanecarboxamide
  参考文献：
  名称：

  Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain

  摘要：

  A series of novel isoxazole voltage gated sodium channel blockers have been synthesized and evaluated. Substitutions on the benzylic position of benzamide were investigated to determine their effect on Na(v)1.7 inhibitory potency. The spirocyclobutyl substitution had the most significant enhancement on Na(v)1.7 inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.07.135
• 作为产物：
  描述：

  在 盐酸 、 水 作用下， 以 甲醇 为溶剂， 反应 1.0h， 以95%的产率得到1-[3-(Trifluoromethyl)phenyl]cyclobutan-1-amine
  参考文献：
  名称：

  Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain

  摘要：

  A series of novel isoxazole voltage gated sodium channel blockers have been synthesized and evaluated. Substitutions on the benzylic position of benzamide were investigated to determine their effect on Na(v)1.7 inhibitory potency. The spirocyclobutyl substitution had the most significant enhancement on Na(v)1.7 inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.07.135

文献信息

• [EN] OXADIAZOLE AMINE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br/>[FR] COMPOSÉS DÉRIVÉS D'OXADIAZOLE AMINE UTILISÉS EN TANT QU'INHIBITEUR DE L'HISTONE DÉSACÉTYLASE 6, ET COMPOSITION PHARMACEUTIQUE LES COMPRENANT
  申请人：CHONG KUN DANG PHARMACEUTICAL CORP

  公开号：WO2017065473A1

  公开（公告）日：2017-04-20

  The present disclosure relates to novel compounds having histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds. The novel compounds, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present disclosure have histone deacetylase (HDAC) inhibitory activity and are effective for the prevention or treatment of HDAC6-mediated diseases, including infectious diseases; neoplasms; endocrine, nutritional and metabolic diseases; mental and behavioral disorders; neurological diseases; diseases of the eye and adnexa; cardiovascular diseases; respiratory diseases; digestive diseases; diseases of the skin and subcutaneous tissue; diseases of the musculoskeletal system and connective tissue; or congenital malformations, deformations and chromosomal abnormalities.
• Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain
  作者：Pengcheng P. Shao、Feng Ye、Ann E. Weber、Xiaohua Li、Kathryn A. Lyons、William H. Parsons、Maria L. Garcia、Birgit T. Priest、McHardy M. Smith、John P. Felix、Brande S. Williams、Gregory J. Kaczorowski、Erin McGowan、Catherine Abbadie、William J. Martin、Daniel R. McMasters、Ying-Duo Gao

  DOI：10.1016/j.bmcl.2009.07.135

  日期：2009.9

  A series of novel isoxazole voltage gated sodium channel blockers have been synthesized and evaluated. Substitutions on the benzylic position of benzamide were investigated to determine their effect on Na(v)1.7 inhibitory potency. The spirocyclobutyl substitution had the most significant enhancement on Na(v)1.7 inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.